Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02944344 · ClinicalTrials.gov registry record · NA

Four Conversations RCT

A NA study of Breast Cancer, sponsored by Duke University.

Completed
Registry status
NA
Development phase
357
Enrollment target
1
Study location

NCT02944344: Completed NA study of Breast Cancer, sponsored by Duke University.

NCT02944344 is a NA study of Breast Cancer that has completed, run by Duke University. The registered enrollment target is 357 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02944344, a NA study of Breast Cancer, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
357 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see whether patients with metastatic breast cancer, their caregivers, and their healthcare providers can improve in shared decision making (SDM) and preparedness around end of life (EOL) planning through participation in Reimagine's online Four Conversations™ program. The goal is to close clinical practice gaps and enhance the quality of care for patients with metastatic breast cancer through increased competence and performance of healthcare providers and healthcare systems.

Primary Outcome

The Preparation for Decision Making Scale is a reliable and validated self-reported measure of the patient/caregiver or provider's perception of how useful a decision support intervention is in preparing the respondent to communicate with others making a health decision. Items are summed and scored, then divided by 10; scores can be converted to a 0-100 scale. Higher scores indicate higher perceived level of preparation for decision making.

Conditions Studied

Interventions

  • BEHAVIORAL Four Conversations

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 357 participants
Start Date 2016-12-15
Est. Completion 2018-10-21
Phase NA
Duke University

1,725 total trials

What the finished NCT02944344 record still lists

NCT02944344 is an interventional study that assigns participants to a tested intervention. The registered 357 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Four Conversations is the first listed.

NCT02944344 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02944344 about?

NCT02944344 is a clinical study titled "Four Conversations RCT". The purpose of this study is to see whether patients with metastatic breast cancer, their caregivers, and their healthcare providers can improve in shared decision making (SDM) and preparedness around end of life (EOL) planning through participation in Reimagine's online Four Conversations™ program....

What is the current status of trial NCT02944344?

This trial is currently completed. It is a NA study. The enrollment target is 357 participants. The study started on 2016-12-15. Estimated completion is 2018-10-21.

What conditions does trial NCT02944344 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02944344?

The interventions under investigation include: Four Conversations (BEHAVIORAL).

Who is sponsoring clinical trial NCT02944344?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02944344 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02944344's enrollment target sits among peer trials

357 254th of 1224 higher than 970 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06062888 · 357 participants · Phase 2

    FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial

  • NCT06109766 · 357 participants · NA

    Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth

  • NCT06231342 · 357 participants · NA

    Endotracheal Tube (ETT) 180: Stylet-loaded Endotracheal Tube Rotation Before Insertion

  • NCT06679621 · 357 participants · NA

    A Telehealth Intervention to Increase Patient Preparedness for Surgery in Latinas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02944344, the US trial registry maintained by the National Library of Medicine. NCT02944344 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.